274 related articles for article (PubMed ID: 30191046)
1. Dysregulated fatty acid metabolism in hepatocellular carcinoma.
Wang M; Han J; Xing H; Zhang H; Li Z; Liang L; Li C; Dai S; Wu M; Shen F; Yang T
Hepat Oncol; 2016 Oct; 3(4):241-251. PubMed ID: 30191046
[TBL] [Abstract][Full Text] [Related]
2. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
4. Aberrant lipid metabolism as a therapeutic target in liver cancer.
Pope ED; Kimbrough EO; Vemireddy LP; Surapaneni PK; Copland JA; Mody K
Expert Opin Ther Targets; 2019 Jun; 23(6):473-483. PubMed ID: 31076001
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.
Lee S; Mardinoglu A; Zhang C; Lee D; Nielsen J
Nucleic Acids Res; 2016 Jul; 44(12):5529-39. PubMed ID: 27216817
[TBL] [Abstract][Full Text] [Related]
6. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma.
Nakagawa H; Hayata Y; Kawamura S; Yamada T; Fujiwara N; Koike K
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30445800
[TBL] [Abstract][Full Text] [Related]
7. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma.
Sangineto M; Villani R; Cavallone F; Romano A; Loizzi D; Serviddio G
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486341
[No Abstract] [Full Text] [Related]
8. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid metabolic enzyme acyl-CoA thioesterase 8 promotes the development of hepatocellular carcinoma.
Hung YH; Chan YS; Chang YS; Lee KT; Hsu HP; Yen MC; Chen WC; Wang CY; Lai MD
Oncol Rep; 2014 Jun; 31(6):2797-803. PubMed ID: 24788990
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
Baffy G; Brunt EM; Caldwell SH
J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
13. Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance.
Khalaf AM; Fuentes D; Morshid AI; Burke MR; Kaseb AO; Hassan M; Hazle JD; Elsayes KM
J Hepatocell Carcinoma; 2018; 5():61-73. PubMed ID: 29984212
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review.
Mizuguchi Y; Takizawa T; Yoshida H; Uchida E
Hepatol Res; 2016 Mar; 46(5):391-406. PubMed ID: 26490438
[TBL] [Abstract][Full Text] [Related]
16. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Zhang C; Wang P; Li Y; Huang C; Ni W; Chen Y; Shi J; Chen G; Hu X; Ye M; Duan S; Wang K
Anat Rec (Hoboken); 2019 Feb; 302(2):193-200. PubMed ID: 30312023
[TBL] [Abstract][Full Text] [Related]
17. Integrative transcriptome analysis of liver cancer profiles identifies upstream regulators and clinical significance of ACSM3 gene expression.
Gopal R; Selvarasu K; Pandian PP; Ganesan K
Cell Oncol (Dordr); 2017 Jun; 40(3):219-233. PubMed ID: 28390038
[TBL] [Abstract][Full Text] [Related]
18. Aberrant regulation of Wnt signaling in hepatocellular carcinoma.
Liu LJ; Xie SX; Chen YT; Xue JL; Zhang CJ; Zhu F
World J Gastroenterol; 2016 Sep; 22(33):7486-99. PubMed ID: 27672271
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of mRNA expressions of apolipoprotein A and C family genes in hepatitis B virus-related hepatocellular carcinoma.
Wang X; Gong Y; Deng T; Zhang L; Liao X; Han C; Yang C; Huang J; Wang Q; Song X; Zhang T; Yu T; Zhu G; Ye X; Peng T
J Cell Biochem; 2019 Oct; 120(10):18246-18265. PubMed ID: 31211449
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of hepatocellular carcinoma.
Kirstein MM; Vogel A
Dig Dis; 2014; 32(5):545-53. PubMed ID: 25034287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
